Direxion Daily S&P Biotech Bull 3X Shares

Apple hits new 12-month low as Tuesday is marked by random action not trusted by traders.

There's a flaw with most contrarian arguments.

A little bounce action arrived Tuesday morning, and here's how I'm handling the market move -- and what I'll do if it keeps up.

I'm adding to several stocks, but will get more aggressive if we see a negative reaction this afternoon.

Let's look at how the fear is shifting from inflation to recession -- and trades I'm watching now.

The question is, how far will traders push at this point before they take profits and start positioning for a pullback?

There still are very limited pockets of momentum, but the tone of the action is improving.

It feels frothy out there.

It's important to keep in mind that this action is driven from the top down.

The SPDR S&P Biotech ETF is one for traders to keep on their radar.

A sustained rally in ARK-like names would be a welcome sight for us momentum traders.

Here are several names I'm watching right now.

The issue is whether or not the inflation number is already priced in.

Yet there's good relative strength in biotech, growth, cannabis, small-caps, and other sectors that have been the biggest laggards.

What's notable is there is not the same intense selling in many of the stocks that did so poorly Wednesday.

This is good action for rebuilding some very badly broken charts.

Small-cap biotech names are seeing dramatic, widespread declines, creating a liquidation sale for investors.

I believe this is just bounce action at this point and not a bottom, but I'm playing it.

Small-caps are lagging and breadth is negative, but the computer algorithms are very impressive.

The retail goliath has more plans for its brick-and-mortar operations.

The retailer is making a swift change to a previously lenient policy.

Netflix announces major price hikes in its membership tiers and its shares skyrocket.